niacinamide has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib was originally developed as a BRAF inhibitor, but our work demonstrates that sorafenib can also be used to treat FIP1L1-PDGFRA positive leukemia, demonstrating that new therapies to treat rare leukemias may be simply found by testing drugs that are already in use for the treatment of other diseases." | 1.36 | Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia. ( Cools, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cools, J | 1 |
| Inuzuka, H | 1 |
| Shaik, S | 1 |
| Onoyama, I | 1 |
| Gao, D | 1 |
| Tseng, A | 1 |
| Maser, RS | 1 |
| Zhai, B | 1 |
| Wan, L | 1 |
| Gutierrez, A | 1 |
| Lau, AW | 1 |
| Xiao, Y | 1 |
| Christie, AL | 1 |
| Aster, J | 1 |
| Settleman, J | 1 |
| Gygi, SP | 1 |
| Kung, AL | 1 |
| Look, T | 1 |
| Nakayama, KI | 1 |
| DePinho, RA | 1 |
| Wei, W | 1 |
2 other studies available for niacinamide and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia.
Topics: Benzenesulfonates; Humans; Hypereosinophilic Syndrome; mRNA Cleavage and Polyadenylation Factors; Ni | 2010 |
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Topics: Amino Acid Sequence; Animals; Apoptosis; Benzenesulfonates; Biphenyl Compounds; Cell Cycle Proteins; | 2011 |